Literature DB >> 2422449

Cloning of the human oestrogen receptor cDNA.

S Green, P Walter, G Greene, A Krust, C Goffin, E Jensen, G Scrace, M Waterfield, P Chambon.   

Abstract

Poly A+ RNA isolated from the human breast cancer cell line MCF-7 was fractionated by sucrose gradient centrifugation and those fractions enriched in oestrogen receptor (ER) mRNA were used to prepare randomly primed cDNA libraries in the lambda gt11 vectors. Clones corresponding to the ER were isolated from both libraries after screening with either ER monoclonal antibodies (lambda gt11) or synthetic oligonucleotide probes designed from two peptide sequences of purified ER (lambda gt10). Five cDNA clones were isolated by antibody screening and five after screening with synthetic oligonucleotides. The two largest ER cDNA clones, lambda OR3 (1.3 kbase) and lambda OR8 (2.1 kbase), isolated using antibodies and oligonucleotides, respectively, were able to enrich selectively for ER mRNA by hybrid-selection. Furthermore, lambda OR8 contains DNA sequences which cross-hybridize with each of the other ER cDNA clones. These results demonstrate that the clones isolated correspond to the ER mRNA sequence. Using lambda OR8 as a hybridization probe revealed a single poly A+ RNA band of approx. 6.2 kbase in the ER containing human breast cancer cell lines MCF-7 and T47D. In contrast, no hybridization was seen in the human ER-cell line HeLa. The same probe hybridizes to a chicken gene which is expressed in oviduct tissue as a 7.5 kbase poly A+ RNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422449     DOI: 10.1016/0022-4731(86)90035-x

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  56 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

3.  Epigenetic Reactivation of Estrogen Receptor: Promising Tools for Restoring Response to Endocrine Therapy.

Authors:  Neeraj K Saxena; Dipali Sharma
Journal:  Mol Cell Pharmacol       Date:  2010

Review 4.  Roles of oestrogen receptors alpha and beta in behavioural neuroendocrinology: beyond Yin/Yang.

Authors:  E F Rissman
Journal:  J Neuroendocrinol       Date:  2008-06       Impact factor: 3.627

5.  Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro.

Authors:  Qi YE; Qiao-yan ZHANG; Cheng-jian ZHENG; Yang WANG; Lu-ping QIN
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

6.  Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats.

Authors:  Saloua Benmansour; Opeyemi S Adeniji; Anthony A Privratsky; Alan Frazer
Journal:  Neuroendocrinology       Date:  2015-07-01       Impact factor: 4.914

7.  Lost in translation: can we afford to miss the trees for the forest?

Authors:  Stephen R Hammes; Carol A Lange
Journal:  Horm Cancer       Date:  2014-08       Impact factor: 3.869

Review 8.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.

Authors:  Matthias Barton; Edward J Filardo; Stephen J Lolait; Peter Thomas; Marcello Maggiolini; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-25       Impact factor: 4.292

Review 9.  Extranuclear signaling by ovarian steroids in the regulation of sexual receptivity.

Authors:  Paul E Micevych; Kevin Sinchak
Journal:  Horm Behav       Date:  2018-05-18       Impact factor: 3.587

10.  Expression of estrogen and progesterone receptors in the bovine ovary during estrous cycle and pregnancy.

Authors:  Bajram Berisha; Michael W Pfaffl; Dieter Schams
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.